Cas:1309-56-4 molybdenum(iv) sulfide manufacturer & supplier

Chemical Name:molybdenum(iv) sulfide

CAS.NO:1309-56-4

Synonyms:EINECS 215-263-9;MFCD00003470

Molecular Formula:MoS₂

Molecular Weight:160.09000

HS Code:

Physical and Chemical Properties:

Melting point:2375ºC

Boiling point:N/A

Density:5.06 g/mL at 25ºC(lit.)

Index of Refraction:

PSA:64.18000

Exact Mass:161.85000

LogP:1.29640

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like EINECS 215-263-9 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00003470 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00003470 Use and application,EINECS 215-263-9 technical grade,usp/ep/jp grade.

Related News: At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. molybdenum(iv) sulfide manufacturer According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter. molybdenum(iv) sulfide supplier With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines. molybdenum(iv) sulfide vendor Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. molybdenum(iv) sulfide factory With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.